King International Investment (HKSE:00928) ROCE % : 2.36% (As of Sep. 2023)

View and export this data going back to 2002. Start your Free Trial

What is King International Investment ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. King International Investment's annualized ROCE % for the quarter that ended in Sep. 2023 was 2.36%.

King International Investment ROCE % Historical Data

The historical data trend for King International Investment's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

King International Investment ROCE % Chart

King International Investment Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

-35.24

-8.50

0.26

-13.14

-12.22

King International Investment Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
ROCE %	Get a 7-Day Free Trial															-2.53	-23.65	-0.98	-23.31	2.36

King International Investment ROCE % Calculation

King International Investment's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	-30.482	/	( ( (302.94 - 39.383)	+	(264.269 - 28.812) )	/ 2 )
	=	-30.482	/	( (263.557	+	235.457)	/ 2 )
	=	-30.482	/	249.507
	=	-12.22 %

King International Investment's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Mar. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Mar. 2023 )		(Q: Sep. 2023 )
	=	5.564	/	( ( (264.269 - 28.812)	+	(290.67 - 55.517) )	/ 2 )
	=	5.564	/	( ( 235.457	+	235.153 )	/ 2 )
	=	5.564	/	235.305
	=	2.36 %

(1) Note: The EBIT data used here is two times the semi-annual (Sep. 2023) EBIT data.

King International Investment (HKSE:00928) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

King International Investment ROCE % Related Terms

Thank you for viewing the detailed overview of King International Investment's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

King International Investment (HKSE:00928) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » King International Investment Ltd (HKSE:00928) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 Harbour Road, Room 6307-08, 63rd Floor, Central Plaza, Wanchai, Hong Kong, HKG

Website

https://www.lifehealthcare.com

King International Investment Ltd formerly Life Healthcare Group Ltd is an investment holding company. The company's operating segment includes the Healthcare products and services business and Money lending business. It generates maximum revenue from the Healthcare products and services business segment. Geographically, it derives a majority of revenue from PRC. The group is primarily a provider of genetic testing and health data analysis services.

King International Investment (HKSE:00928) Headlines

No Headlines